Cargando…
A treatment dilemma in adult immunoglobulin A nephropathy: what is the appropriate target, preservation of kidney function or induction of clinical remission?
Immunoglobulin (Ig) A nephropathy is the most common type of glomerulonephritis worldwide. Data on its natural history suggest that approximately 40% of patients progress to end-stage renal failure after 20 years. Various therapies such as antiplatelet medication, fish oil, oral prednisolone, intrav...
Autores principales: | Imai, Hirokazu, Miura, Naoto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328677/ https://www.ncbi.nlm.nih.gov/pubmed/22086123 http://dx.doi.org/10.1007/s10157-011-0552-8 |
Ejemplares similares
-
Estimated glomerular filtration rate and daily amount of urinary protein predict the clinical remission rate of tonsillectomy plus steroid pulse therapy for IgA nephropathy
por: Suzuki, Keisuke, et al.
Publicado: (2013) -
Immunoglobulin A nephropathy in remission: a case report
por: Mahat, Asim, et al.
Publicado: (2023) -
Glomerular tip adhesions predict the progression of IgA nephropathy
por: Maeda, Kunihiro, et al.
Publicado: (2013) -
Remission Induction of IgG4-related Membranous Nephropathy with Multitarget Therapy
por: Furuto, Yoshitaka, et al.
Publicado: (2023) -
Recurrent Crescentic Immunoglobulin A Nephropathy in the Graft Kidney
por: Bhargava, V.
Publicado: (2017)